Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Children's Hospital of Eastern Ontario | OTHER |
| Maternal Infant Child and Youth Research Network | UNKNOWN |
| The Hospital for Sick Children | OTHER |
Not provided
Not provided
Not provided
Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. In pediatrics, investigations or treatments can be unpleasant or traumatizing to the child, can prolong the time spent in hospital, and can create a cascade of further futile investigations and treatments. Several of the commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics.
The purpose of CareBEST is to study the use of 6 low-value healthcare services in children aged 1 to 12 months hospitalized with bronchiolitis, their costs, and measure the variability in practice of these services.
The main questions this study aims to answer are:
How frequently are 6 low-value care health services used in children hospitalized with bronchiolitis? These 6 low-value care health services are: 1) respiratory virus testing; 2) chest x-rays; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics.
How much variability is there between different patients, different doctors, and between hospitals in the use of these 6 low-value health services ?
Are differences in use of low-value health services associated with patient and family characteristics (like race and ethnicity, socioeconomic status, language), and do these contribute to disparities in care?
Participants will have their infant's medical chart reviewed during their hospitalization. They will also have 2 short questionnaires to complete, once during their child's admission to the hospital, and one 30 days later to ask about whether their child required any additional medical care. They will additionally be asked to complete a questionnaire on their perceptions regarding their child's care while hospitalized, including the use of shared-decision making and their understanding of and involvement in the care decisions made.
This analysis will provide a better understanding of treatment of bronchiolitis in Canada and help in the development of effective interventions to reduce low-value care.
Background: Low-value care is defined as the use of a health service, such as diagnostics and treatments, for which the harms or costs outweigh the benefits. Reducing low-value care is important in improving the health of Canadians and achieving a sustainable, high-quality healthcare system. Bronchiolitis is among the most common and most costly causes of hospitalizations in children. Most healthcare costs associated with bronchiolitis are related to hospitalization, and these costs have been increasing. Supportive care is recommended by national guidelines for the treatment of bronchiolitis, and many commonly used diagnostics and treatments in bronchiolitis are considered low-value, making it a great model to study low-value care in pediatrics. To develop effective interventions to reduce low-value care, and ensure the right resources go to the right patient at the right time, it is crucial to develop a better understanding of inpatient management of bronchiolitis in Canada.
The goal of this prospective multi-site observational study is to analyze the use of 6 low-value healthcare services in children diagnosed with bronchiolitis, their costs, and measure the variability in practice of these services.
Specific objectives: Among infants admitted with bronchiolitis at 15 Canadian hospitals with pediatric admissions, to:
Design: A multi-centre (n=15), prospective observational cohort study of children hospitalized with bronchiolitis. Data will be obtained from medical charts and entered into a central, web-based REDCap database. A health equity questionnaire will be completed by participants once during their child's admission and then again 30 days later to inquire on additional medical care required post-admission. Secondary outcomes and covariates will also be collected which include but are not limited to duration of ICU stay, use of mechanical ventilation, cardiac arrest, length of hospital stay, disease severity, clinician years of experience, and death.
Analysis of the primary outcome will be descriptive for each low-value health service, overall and stratified by sex. Costs of hospitalization will be assessed from a healthcare institution perspective. Cost of each of low-value health service will be described and compared between one another and across sites to identify key differences which may be targets for process change.
This study will provide important data to understand the use of low-value care in bronchiolitis treatment in Canada, and will inform our approach to addressing low-value care in bronchiolitis and in other common conditions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Children admitted to CHU Sainte-Justine | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| |
| Children admitted to McMaster Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| |
| Children admitted to British Columbia Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| |
| Children admitted to IWK Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| |
| Children admitted to CHU de Quebec University Laval Hospital |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Provision of any of six different low-value health services for treatment of bronchiolitis | Diagnostic Test | This prospective observational will have six separate primary outcomes acting as exposures, (or interventions).The exposures are the the provision of any of the six low-value health services: 1) respiratory virus testing; 2) chest x-ray; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics. |
| Measure | Description | Time Frame |
|---|---|---|
| The proportion of eligible patients receiving each of the six low-value health services | The primary outcome of the study is the proportion of patients receiving each of the six low-value health services during their hospitalization for bronchiolitis: 1) respiratory virus testing; 2) chest x-ray; 3) continuous pulse oximetry; 4) short-acting beta-agonists; 5) systemic corticosteroids; and 6) antibiotics. | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Transfer to the ICU | Whether the child admitted with bronchiolitis was transferred to the ICU. If so, duration of ICU stay. | 24 months |
| Use of CPAP, BiPAP, or mechanical ventilation during admission. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Children previously recruited for the study, either during a previous bronchiolitis admission or for the same incident of bronchiolitis, while admitted to another study site.
Not provided
Not provided
Not provided
Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Olivier Drouin, MD, MSc, MPH | Contact | 514 345-4931 | 4226 | olivier.drouin.hsj@ssss.gouv.qc.ca |
| Tamara Perez, MSc | Contact | tamara.perez.hsj@ssss.gouv.qc.ca |
| Name | Affiliation | Role |
|---|---|---|
| Olivier Drouin, MD, MSc, MPH | CHU Sainte-Justine Research Centre | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alberta Children's Hospital | Recruiting | Calgary | Alberta | T3B 6A8 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Unity Health Toronto |
| OTHER |
Not provided
Not provided
Not provided
Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Montreal Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Children's Hospital of Eastern Ontario | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Kingston Health Sciences Centre | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to The Hospital for Sick Children | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
| Children admitted to Children's Hospital of Western Ontario | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Alberta Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Stollery Children's Hospital | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children Admitted to Hôpital Maisonneuve-Rosemont | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Cité-de-la-Santé | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
| Children admitted to Lakeridge Health | Children aged >28 days to <12 months with an admission diagnosis of bronchiolitis, admitted to a general pediatric inpatient unit, not previously recruited for the study. |
|
|
Use of continuous positive airway pressure (CPAP) or biphasic positive airway pressure (BiPAP), mechanical ventilation during admission, as documented in patient's admission record.
| 24 months |
| Cardiac arrest | Whether the child experienced a cardiac arrest during their admission. | 24 months |
| Death | Whether the child died during their admission. | 24 months |
| Return visits | Using administrative data and parent surveys, we will measure return visits to the Emergency Department, and hospitalizations within 30 days following the initial bronchiolitis admission, overall and for respiratory illness. | 24 months |
| Use of low-flow supplemental oxygen | Any use of low-flow supplemental oxygen, and duration of use. | 24 months |
| Fluid supplementation | Presence and type (intravenous vs. nasogastric) of fluid supplementation | 24 months |
| Nil per os order | Any order for "nil per os" (feeding not permitted) during admission. | 24 months |
| Chest X-ray results | Results of chest X-rays ordered. Obtained from medical record. | 24 months |
| Presence of bacterial co-infection | Presence and type of bacterial co-infections. Obtained from medical record. | 24 months |
| Use of inhaled corticosteroids | Whether inhaled corticosteroids were administered during admission. Obtained from medical record. | 24 months |
| Use of chest physiotherapy | Whether chest physiotherapy was performed during admission. Obtained from medical record. | 24 months |
| Complete blood count | Results of complete blood count. Obtained from medical record. Numerical | 24 months |
| Electrolyte levels | Electrolyte levels in blood. Obtained from medical record. Numerical | 24 months |
| Venous blood gas | Results of blood tests ordered; venous blood gas. Obtained from medical record. Numerical | 24 months |
| Antiviral prescription | Any prescription for an antiviral effective against influenza during admission.Obtained from medical record. | 24 months |
| Prescription at discharge from hospital | Data collection on prescription at discharge from the hospital including the following: 1) repeat chest x-ray; 2) prescription for short-acting beta-agonists (SABA); 3) inhaled corticosteroids; 4) systemic corticosteroids; 5) antibiotics; and 6) antivirals. | 24 months |
| Care received in the 30 days following discharge. | Care received in the 30 days following the patient's discharge from the hospital, including outpatient follow-up appointments in the following 30 days, follow-up chest x-rays, as well as prescription for antibiotics, short-acting beta-agonists, and inhaled corticosteroids. | 24 months |
| Length of stay | Length of hospital stay in hours, both in the ED and inpatient unit, measured using recorded time of arrival and departure to and from the ED and inpatient unit. | 24 months |
| Cost of hospitalization | Cost of hospitalization will be evaluated from a healthcare institution perspective with data from hospital decision support. More detailed costs data (micro-costing) will also be obtained whenever possible, allowing differentiation between services not readily discerned by traditional case costing methods typically based on resource intensity weights. | 24 months |
| Use of Heated humidified high-flow nasal cannula (HHHFNC) | Heated humidified high-flow nasal cannula (HHHFNC) help reduce work of breathing and can be beneficial in severe bronchiolitis cases. We will measure proportion of HHHFNC use in hospitalized children with bronchiolitis stratified by disease severity. Obtained from medical record. | 24 months |
| Stollery Children's Hospital | Not yet recruiting | Edmonton | Alberta | T6G 2B7 | Canada |
|
| British Columbia Children's Hospital | Recruiting | Vancouver | British Columbia | V6H 3N1 | Canada |
|
| IWK Health | Active, not recruiting | Halifax | Nova Scotia | B3K 6R8 | Canada |
| McMaster Children's Hospital | Recruiting | Hamilton | Ontario | L8N 3Z5 | Canada |
|
| Kingston Health Science Centre | Not yet recruiting | Kingston | Ontario | K7L 2V7 | Canada |
|
| Children's Hospital of Western Ontario (London Health Science Centre) | Not yet recruiting | London | Ontario | N6C 0B2 | Canada |
|
| Lakeridge Health | Recruiting | Oshawa | Ontario | L1G 8A2 | Canada |
|
| Children's Hospital of Eastern Ontario | Not yet recruiting | Ottawa | Ontario | K1H 8L1 | Canada |
|
| Hospital for Sick Children | Not yet recruiting | Toronto | Ontario | M5G 1E8 | Canada |
|
| Centre hospitalier Cité-de-la-Santé | Recruiting | Laval | Quebec | H7M 3L9 | Canada |
|
| Hôpital Maisonneuve-Rosemont | Recruiting | Montreal | Quebec | H1T 2M4 | Canada |
|
| CHU Sainte-Justine | Recruiting | Montreal | Quebec | H3T 1C5 | Canada |
|
| Montreal Children's Hospital | Not yet recruiting | Montreal | Quebec | H4A 3J1 | Canada |
|
| Centre Hospitalier Université Laval - Centre Mère-Enfant Soleil | Active, not recruiting | Québec | Quebec | G1V 4G2 | Canada |
| ID | Term |
|---|---|
| D001988 | Bronchiolitis |
| ID | Term |
|---|---|
| D001991 | Bronchitis |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided